Auron Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Auron Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS (NCT06846606) | Auron Therapeutics, Inc. | 2025-05-01 |
Track Auron Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.